-
公开(公告)号:CS9103545A3
公开(公告)日:1992-06-17
申请号:CS354591
申请日:1991-11-22
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , HENNING RAINER DR , NICKEL WOLF-ULRICH DR
IPC: A61K31/41 , A61K31/425 , A61P9/12 , A61P43/00 , C07D263/06 , C07D417/04 , C07D417/06 , C12N9/99 , C07D263/04 , A61K31/42
CPC classification number: C07D417/04 , C07D263/06 , C07D417/06
-
公开(公告)号:DE4023215A1
公开(公告)日:1992-01-23
申请号:DE4023215
申请日:1990-07-21
Applicant: HOECHST AG
IPC: A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/425 , A61K31/44 , A61K31/495 , A61K31/505 , A61P1/16 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/12 , A61P43/00 , C07D233/56 , C07D233/90 , C07D403/10 , C07D413/10 , C07D417/10 , C07D417/12 , C07D471/04 , C07D473/00 , C07D487/04 , C07D498/04 , C07D513/04
Abstract: Substd. azole derivs. of formula (I) and their physiologically acceptable salts are new. In (I) X, Y and Z are each N or CR2 R1 is 2-10C alkyl, 3-10C alkenyl, 3-10C alkynyl, -(CH2)mB(CH2nR4 (these 4 gps. opt. monosubstd. with CO2R3 and opt. have 1-all H atoms replaced by F), OR3, 3-8C cycloalkyl, 5-10C cycloalkylalkynyl, or benzyl (opt. mono or disubstd. on the Ph ring with halogen, 1-4C alkoxy and/or NO2), R2 = H, halogen, CvF2v+1, SF5, pentafluoro phenyl CN, phenyl, -(CH2)nF, -(CH2)nONO2, -CH2N3, -(CH2)nNO2, phthalimido (CH2)n-, R3 = H, 1-8C alkyl (in which 1 to all H are replaced by F), 3-8C cycloalkyl, Ph or benzyl, R4 = H, 1-6C alkyl, 3-8C cycloalkyl, 2-4C alkenyl, or 2-4C alkynyl, A = a mono or bicyclic unsatd. or partially hydrogenated heterocycle gp. with 5-10 ring atom of which up to 9 are C, and opt. substd. with up to 3 opt. different R14 gps. or -(CH2)n-1-(CHR6CH2)0-1, R14 where R14 = halogen, oxo, nitroso, NO2, amino, CN, OH, 1-6C alkyl, 1-4C alkanoyl, 1-4C alkanoyloxy. B = O, NR7 or S, W = O or S, L = 1-3C alkanediyl, R26 and R27 are each H, halogen, NO2, 1-4C alkyl or 1-2C alkoxy, n = 1-5, o = 1-10, q = 0-1.
-
公开(公告)号:CS9100906A2
公开(公告)日:1991-11-12
申请号:CS90691
申请日:1991-04-02
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , HENNING RAINER DR , GERHARDS HERMANN DR , SCHOLKENS BERNHARD DR
IPC: A61K31/415 , A61K31/38 , A61K31/40 , A61K31/41 , A61K31/4155 , A61K31/4164 , A61K31/423 , A61K31/437 , A61K31/44 , A61K31/443 , A61K31/4433 , A61K31/495 , A61K31/505 , A61K31/519 , A61P9/12 , A61P29/00 , A61P43/00 , C07D233/64 , C07D233/84 , C07D233/90 , C07D403/06 , C07D405/06 , C07D409/06 , C07D409/14 , C07D413/06 , C07D471/04 , C07D487/04
Abstract: The invention relates to compounds of the formula in which X, Y and Z are identical or different and are N or CR , R and R are as defined in the description, L is an alkylene radical, q = 0 or 1, and A is the radical of a fused heterobicycle. The invention furthermore relates to a method for the preparation of the abovementioned compounds, to compositions containing them, and to their use.
-
公开(公告)号:CS9001980A2
公开(公告)日:1991-08-13
申请号:CS198090
申请日:1990-04-20
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , URBACH HANSJORG DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , SCHOLKENS BERNWARD PROF DR
IPC: A61K38/55 , A61K38/00 , A61P9/00 , A61P9/12 , C07K1/06 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/065 , C07K14/81 , C07K5/08
CPC classification number: C07K5/06078 , A61K38/00 , C07K5/0227
-
公开(公告)号:CS9001979A2
公开(公告)日:1991-08-13
申请号:CS197990
申请日:1990-04-20
Applicant: HOECHST AG
Inventor: NICKEL WOLF-ULRICH DR , LINZ WOLFGANG DR , RUPPERT DIETER DR , URBACH HANSJORG DR , WAGNER ADALBERT DR
IPC: A61K38/55 , A61K38/00 , A61K38/05 , A61P9/12 , C07K1/06 , C07K1/113 , C07K5/06 , C07K5/065 , C07K14/81 , C07K7/00
CPC classification number: C07K5/06078 , A61K38/00
-
公开(公告)号:DE3924506A1
公开(公告)日:1991-01-31
申请号:DE3924506
申请日:1989-07-25
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJOERG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMER WERNER DR
IPC: C07C237/08 , C07C237/22 , C07D233/54 , C07D401/12 , C07D403/12 , C07D409/12 , C07K5/065 , C07K5/078
Abstract: Peptide polyhydroxyalkylamides of formula (I) and their salts are new; where A = R1R6N-CHR5-CO-, R1R7CH-CHR5-CO- or R1O-CHR5-CO-; R1 = R'1 or R'1W; R'1 = (a) 3-8C cycloalkyl, CONH2, OCH2COOH, NH2, etc. (b) H, OH or 1-4C alkoxy, (c) 1-18C alkyl, quanidino, phenyl(1-4C)alkoxy, etc. (d) 6-14C aryl, (6-14C)aryl(1-4C)alkyl, etc. (e) Het or Het(1-4C)alkyl, where Het is an opt. benzo-fused 5- to 7-membered heterocyclic ring contg. 1 or 2 of N, O, S, No, etc. (f) NR8R9; Het or Het(1-4C)alkyl, or NR8R9 is a mono- or bicyclic 5- to 12-membered ring system opt. contg. 1 or 2 more N atoms, an S atom or an O atom, opt. substd. by 1-4C alkyl; W = CO, CS, OSO, SO2, SO, NHSO2, NHCO, CHOH or NOH; n = 2-10.
-
公开(公告)号:DE3627877A1
公开(公告)日:1988-02-04
申请号:DE3627877
申请日:1986-08-16
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , KLEEMANN HEINZ-WERNER DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD DR
IPC: A61K31/415 , A61K38/00 , C07D233/54 , C07D233/64 , C07K1/00 , C07K5/02 , C07K5/06 , C07K5/065 , C07K5/08 , A61K37/02 , A61K37/64
Abstract: The invention relates to compounds of the formula in which R1 is absent or denotes hydrogen, alkyl or acyl, A denotes an acyl radical or an amino acid residue, B denotes an amino acid residue, and R2, R3 and R4 are as defined in the specification, and to their salts, to a process for their preparation, to pharmaceutical products containing them, and to their use as medicaments, and intermediates for the preparation of these compounds.
-
-
-
-
-
-